In 2025, Porton Pharma Solutions conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Waste Generated | 35,405.52a | 34,726.26a | 23,416.06a | |
Total Waste Recovered | 20,412.76a | N/A | N/A | |
Total Hazardous Waste Generated | 34,470.7a | 33,961.47a | 22,680.62a | |
Non-Hazardous Waste Disposed | 735.73a | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, Porton Pharma Solutions generated a total of 35,406metric tonnes of waste.a
Of this amount, 57.65% of Porton Pharma Solutions's total waste generated was recovered through methods such as recycling, reuse, or composting, while 42.35% was disposed of through landfilling, incineration, or combustion.a
In 2025, Porton Pharma Solutions reported a total waste generation of 35,406 metric tonnes, of which 57.65% was recovered through recycling, reuse, or composting.This moderate level of recovery indicates that Porton Pharma Solutions is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.a
Since 2023, Porton Pharma Solutions's total waste generation increased by 51.2%, including a 1.96%increase in 2025, indicating a persistent upward trend that may reflect scaling operations, inefficiencies in resource use, or a lack of effective waste minimization practices.a
In 2025, Porton Pharma Solutions generated a total of 35,406 metric tonnes of waste.a
Of this amount, 97.36% of Porton Pharma Solutions's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.2.64% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2023, Porton Pharma Solutions's total waste generation increased by 51.2%, including a 1.96% rise in 2025, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.a
Over the same period, Porton Pharma Solutions's hazardous waste share remained stable both over the long term and in 2025, reflecting consistent but static performance in managing hazardous materials.a
Overall, Porton Pharma Solutions is producing more waste without a change in hazardousness, implying that operational growth is not being accompanied by stronger safeguards against environmental and human health risks.a
In 2025, Porton Pharma Solutions reported that 34,471 metric tonnes of its total waste output were classified as hazardous. This represents 97.36% of its overall waste generation.a
The company treated this hazardous waste using a combination of methods.A majority (58.64%) was diverted from disposal through recovery-oriented treatments such as recycling or reuse. This suggests that Porton Pharma Solutions has established processes to reduce the environmental burden of its most harmful waste streams.a